cpass sars-cov-2 neutralization antibody detection kit (genscript biotech, leiden, the netherlands) (GenScript corporation)
90
Structured Review
GenScript corporation
cpass sars-cov-2 neutralization antibody detection kit (genscript biotech, leiden, the netherlands)
Cpass Sars Cov 2 Neutralization Antibody Detection Kit (Genscript Biotech, Leiden, The Netherlands), supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cpass+sars-cov-2+neutralization+antibody+detection+kit+(genscript+biotech%2C+leiden%2C+the+netherlands)/cpass+sars+cov+2+neutralization+antibody+detection+kit/pm38132270-54-2-8
Average 90 stars, based on 1 article reviews
Cpass Sars Cov 2 Neutralization Antibody Detection Kit (Genscript Biotech, Leiden, The Netherlands), supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cpass+sars-cov-2+neutralization+antibody+detection+kit+(genscript+biotech%2C+leiden%2C+the+netherlands)/cpass+sars+cov+2+neutralization+antibody+detection+kit/pm38132270-54-2-8
Average 90 stars, based on 1 article reviews
cpass sars-cov-2 neutralization antibody detection kit (genscript biotech, leiden, the netherlands) - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Functional Assay:Article Title: Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort. Article Snippet: The commercial, Article Title: SARS-CoV-2 Infection Enhances Humoral Immune Response in Vaccinated Liver Transplant Recipients Article Snippet: For the functional characterization of serum antibodies in terms of their ability to impede the interaction between the RBD and the human host cell receptor protein angiotensin-converting enzyme 2 (hACE2), and consequently prevent cell entry and, thus, infection, the Article Title: Performance of a Point-of-Care Fluorescence Immunoassay Test to Measure the Anti-Severe Acute Respiratory Syndrome Corona Virus 2 Spike, Receptor Binding Domain Antibody Level Article Snippet: The GenScript Article Title: Performance of a Point-of-Care Fluorescence Immunoassay Test to Measure the Anti-Severe Acute Respiratory Syndrome Corona Virus 2 Spike, Receptor Binding Domain Antibody Level. Article Snippet: The GenScript Article Title: Accuracy of Anti-SARS-CoV-2 Antibody in Comparison with Surrogate Viral Neutralization Test in Persons Living with HIV, Systemic Lupus Erythematosus, and Chronic Kidney Disease Article Snippet: The surrogate viral neutralization test (sVNT) was measured using the GenScript Article Title: SARS-CoV-2 Variant-Specific Antibodies in Vaccinated Inflammatory Bowel Disease Patients Article Snippet: The RBD-binding inhibitory capacity of serum antibodies was assessed using the Article Title: Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort Article Snippet: The commercial, Infection:Article Title: Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort. Article Snippet: The commercial, Article Title: SARS-CoV-2 Infection Enhances Humoral Immune Response in Vaccinated Liver Transplant Recipients Article Snippet: For the functional characterization of serum antibodies in terms of their ability to impede the interaction between the RBD and the human host cell receptor protein angiotensin-converting enzyme 2 (hACE2), and consequently prevent cell entry and, thus, infection, the Article Title: Performance of a Point-of-Care Fluorescence Immunoassay Test to Measure the Anti-Severe Acute Respiratory Syndrome Corona Virus 2 Spike, Receptor Binding Domain Antibody Level Article Snippet: The GenScript Article Title: Performance of a Point-of-Care Fluorescence Immunoassay Test to Measure the Anti-Severe Acute Respiratory Syndrome Corona Virus 2 Spike, Receptor Binding Domain Antibody Level. Article Snippet: The GenScript Article Title: Accuracy of Anti-SARS-CoV-2 Antibody in Comparison with Surrogate Viral Neutralization Test in Persons Living with HIV, Systemic Lupus Erythematosus, and Chronic Kidney Disease Article Snippet: The surrogate viral neutralization test (sVNT) was measured using the GenScript Article Title: SARS-CoV-2 Variant-Specific Antibodies in Vaccinated Inflammatory Bowel Disease Patients Article Snippet: The RBD-binding inhibitory capacity of serum antibodies was assessed using the Article Title: Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort Article Snippet: The commercial, Neutralization:Article Title: Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort. Article Snippet: The commercial, Article Title: SARS-CoV-2 Infection Enhances Humoral Immune Response in Vaccinated Liver Transplant Recipients Article Snippet: For the functional characterization of serum antibodies in terms of their ability to impede the interaction between the RBD and the human host cell receptor protein angiotensin-converting enzyme 2 (hACE2), and consequently prevent cell entry and, thus, infection, the Article Title: Performance of a Point-of-Care Fluorescence Immunoassay Test to Measure the Anti-Severe Acute Respiratory Syndrome Corona Virus 2 Spike, Receptor Binding Domain Antibody Level Article Snippet: The GenScript Article Title: Performance of a Point-of-Care Fluorescence Immunoassay Test to Measure the Anti-Severe Acute Respiratory Syndrome Corona Virus 2 Spike, Receptor Binding Domain Antibody Level. Article Snippet: The GenScript Article Title: Accuracy of Anti-SARS-CoV-2 Antibody in Comparison with Surrogate Viral Neutralization Test in Persons Living with HIV, Systemic Lupus Erythematosus, and Chronic Kidney Disease Article Snippet: The surrogate viral neutralization test (sVNT) was measured using the GenScript Article Title: SARS-CoV-2 Variant-Specific Antibodies in Vaccinated Inflammatory Bowel Disease Patients Article Snippet: The RBD-binding inhibitory capacity of serum antibodies was assessed using the Article Title: Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort Article Snippet: The commercial, Transplantation Assay:Article Title: Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort. Article Snippet: The commercial, Article Title: SARS-CoV-2 Infection Enhances Humoral Immune Response in Vaccinated Liver Transplant Recipients Article Snippet: For the functional characterization of serum antibodies in terms of their ability to impede the interaction between the RBD and the human host cell receptor protein angiotensin-converting enzyme 2 (hACE2), and consequently prevent cell entry and, thus, infection, the Article Title: Performance of a Point-of-Care Fluorescence Immunoassay Test to Measure the Anti-Severe Acute Respiratory Syndrome Corona Virus 2 Spike, Receptor Binding Domain Antibody Level Article Snippet: The GenScript Article Title: Performance of a Point-of-Care Fluorescence Immunoassay Test to Measure the Anti-Severe Acute Respiratory Syndrome Corona Virus 2 Spike, Receptor Binding Domain Antibody Level. Article Snippet: The GenScript Article Title: Accuracy of Anti-SARS-CoV-2 Antibody in Comparison with Surrogate Viral Neutralization Test in Persons Living with HIV, Systemic Lupus Erythematosus, and Chronic Kidney Disease Article Snippet: The surrogate viral neutralization test (sVNT) was measured using the GenScript Article Title: SARS-CoV-2 Variant-Specific Antibodies in Vaccinated Inflammatory Bowel Disease Patients Article Snippet: The RBD-binding inhibitory capacity of serum antibodies was assessed using the Article Title: Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort Article Snippet: The commercial, Activity Assay:Article Title: Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort. Article Snippet: The commercial, Article Title: SARS-CoV-2 Infection Enhances Humoral Immune Response in Vaccinated Liver Transplant Recipients Article Snippet: For the functional characterization of serum antibodies in terms of their ability to impede the interaction between the RBD and the human host cell receptor protein angiotensin-converting enzyme 2 (hACE2), and consequently prevent cell entry and, thus, infection, the Article Title: Performance of a Point-of-Care Fluorescence Immunoassay Test to Measure the Anti-Severe Acute Respiratory Syndrome Corona Virus 2 Spike, Receptor Binding Domain Antibody Level Article Snippet: The GenScript Article Title: Performance of a Point-of-Care Fluorescence Immunoassay Test to Measure the Anti-Severe Acute Respiratory Syndrome Corona Virus 2 Spike, Receptor Binding Domain Antibody Level. Article Snippet: The GenScript Article Title: Accuracy of Anti-SARS-CoV-2 Antibody in Comparison with Surrogate Viral Neutralization Test in Persons Living with HIV, Systemic Lupus Erythematosus, and Chronic Kidney Disease Article Snippet: The surrogate viral neutralization test (sVNT) was measured using the GenScript Article Title: SARS-CoV-2 Variant-Specific Antibodies in Vaccinated Inflammatory Bowel Disease Patients Article Snippet: The RBD-binding inhibitory capacity of serum antibodies was assessed using the Article Title: Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort Article Snippet: The commercial, Derivative Assay:Article Title: Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort. Article Snippet: The commercial, Article Title: SARS-CoV-2 Infection Enhances Humoral Immune Response in Vaccinated Liver Transplant Recipients Article Snippet: For the functional characterization of serum antibodies in terms of their ability to impede the interaction between the RBD and the human host cell receptor protein angiotensin-converting enzyme 2 (hACE2), and consequently prevent cell entry and, thus, infection, the Article Title: Performance of a Point-of-Care Fluorescence Immunoassay Test to Measure the Anti-Severe Acute Respiratory Syndrome Corona Virus 2 Spike, Receptor Binding Domain Antibody Level Article Snippet: The GenScript Article Title: Performance of a Point-of-Care Fluorescence Immunoassay Test to Measure the Anti-Severe Acute Respiratory Syndrome Corona Virus 2 Spike, Receptor Binding Domain Antibody Level. Article Snippet: The GenScript Article Title: Accuracy of Anti-SARS-CoV-2 Antibody in Comparison with Surrogate Viral Neutralization Test in Persons Living with HIV, Systemic Lupus Erythematosus, and Chronic Kidney Disease Article Snippet: The surrogate viral neutralization test (sVNT) was measured using the GenScript Article Title: SARS-CoV-2 Variant-Specific Antibodies in Vaccinated Inflammatory Bowel Disease Patients Article Snippet: The RBD-binding inhibitory capacity of serum antibodies was assessed using the Article Title: Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort Article Snippet: The commercial, |